Projects per year
Organization profile
Organisation profile
The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.
Fingerprint Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Neoplasms
Medicine & Life Sciences
Taiwan
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Meta-Analysis
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Cells
Chemical Compounds
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Tze-Sian Chan
- Taipei Municipal Wanfang Hospital
- TMU Research Center of Cancer Translational Medicine
- Division of Gastroenterology and Hepatology
Person: Researcher
Projects 2011 2020
以非侵入性細胞凋亡偵測平台開發血癌精準醫療研究模式-以CRISPR/Cas9基因與標靶治療費城染色體慢性骨髓性白血病為例
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
通過老藥新用來開發新的肝癌治療選擇(2/2)
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
探討CD155/TIGIT在類骨髓衍生抑制細胞/腫瘤衍生巨噬細胞誘導自然殺手細胞失調的機轉- 研究肺癌病人免疫檢查點阻斷藥物抗藥性機轉
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1958 2020
Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))
Lai, S. C., Su, Y. T., Chi, C. C., Kuo, Y. C., Lee, K. F., Wu, Y. C., Lan, P. C., Yang, M. H., Chang, T. S. & Huang, Y. H., Jan 13 2020, In : Journal of experimental & clinical cancer research : CR. 39, 1, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Intercalating pyrene with polypeptide as a novel self-assembly nano-carrier for colon cancer suppression in vitro and in vivo
Lo, P. Y., Lee, G. Y., Zheng, J. H., Huang, J. H., Cho, E. C. & Lee, K. C., Apr 1 2020, In : Materials Science and Engineering C. 109, 110593.Research output: Contribution to journal › Article
Polypeptides
Pyrene
polypeptides
pyrenes
Self assembly
In vitro and in vivo evaluation of the neuroprotective activity of Uncaria hirsuta Haviland
Lin, C. M., Lin, Y. T., Lee, T. L., Imtiyaz, Z., Hou, W. C. & Lee, M. H., Jan 2020, In : Journal of Food and Drug Analysis. 28, 1, p. 147-158 12 p.Research output: Contribution to journal › Article
Open Access
Uncaria
neuroprotective effect
Inhibitory Concentration 50
inhibitory concentration 50
Oxidopamine